Modulating angiogenesis
    1.
    发明授权
    Modulating angiogenesis 失效
    调节血管发生

    公开(公告)号:US07491389B2

    公开(公告)日:2009-02-17

    申请号:US10392439

    申请日:2003-03-18

    IPC分类号: A61K39/395 A61K39/00

    摘要: Hemangioblasts in adult bone marrow participate in new blood vessel formation. By modulating the differentiation of hemangioblasts into blood vessel cells, angiogenesis in a particular tissue can be increased or decreased. Intravitreal injection of antibodies that block SDF-1 activity inhibited induced retinal neovascularization mediated by hemangioblasts.

    摘要翻译: 成骨髓细胞血管母细胞参与新血管形成。 通过调节成血管细胞分化成血管细胞,可以增加或减少特定组织中的血管发生。 玻璃体内注射阻断SDF-1活性的抗体抑制由成血成血管细胞介导的诱导的视网膜新生血管形成。

    Compounds and method for the prevention and treatment of diabetic retinopathy
    2.
    发明授权
    Compounds and method for the prevention and treatment of diabetic retinopathy 有权
    用于预防和治疗糖尿病性视网膜病变的化合物和方法

    公开(公告)号:US07115566B2

    公开(公告)日:2006-10-03

    申请号:US10412603

    申请日:2003-04-11

    IPC分类号: A61K38/00 C07K2/00 C07K5/00

    摘要: The invention provides peptide derivatives designed to deliver peptides having growth factor inhibitory activity, especially somatostatin analogs, to the retina by sequential metabolism. The peptide derivatives, which comprise a dihydropyridine⇄pyridinium salt-type redox targetor moiety, a bulky lipophilic function and an amino acid/dipeptide/tripeptide spacer, are used in the prevention and treatment of diabetic retinopathy.

    摘要翻译: 本发明提供肽衍生物,其设计用于通过连续代谢将具有生长因子抑制活性的肽(特别是生长抑素类似物)递送至视网膜。 包含二氢吡啶鎓吡啶鎓盐型氧化还原靶标部分,大体积亲脂性功能和氨基酸/二肽/三肽间隔物的肽衍生物用于预防和治疗糖尿病性视网膜病变。

    Arginyl-glutamine dipeptide for treatment of pathological vascular proliferation
    9.
    发明申请
    Arginyl-glutamine dipeptide for treatment of pathological vascular proliferation 有权
    用于治疗病理性血管增生的精氨酰 - 谷氨酰胺二肽

    公开(公告)号:US20070054866A1

    公开(公告)日:2007-03-08

    申请号:US11593699

    申请日:2006-11-06

    申请人: Josef Neu Maria Grant

    发明人: Josef Neu Maria Grant

    IPC分类号: A61K38/04

    摘要: The subject invention provides dipeptides useful in preventing pathological proliferation of blood vessels. The dipeptides of the subject invention are particularly advantageous because they are stable, bioavailable, and can be formulated in an aqueous solution.

    摘要翻译: 本发明提供了可用于预防血管病理增殖的二肽。 本发明的二肽是特别有利的,因为它们是稳定的,生物可利用的,并且可以配制在水溶液中。

    Enternal administration of arginine and glutamine for abnormal vascular proliferation
    10.
    发明申请
    Enternal administration of arginine and glutamine for abnormal vascular proliferation 审中-公开
    精氨酸和谷氨酰胺的异常血管增生的永久管理

    公开(公告)号:US20060229256A1

    公开(公告)日:2006-10-12

    申请号:US11392913

    申请日:2006-03-29

    IPC分类号: A61K38/04 A61K31/198

    CPC分类号: A61K38/05 A61K38/04 A61K38/16

    摘要: The subject invention provides a method and compositions for preventing and/or treating abnormal vascular proliferation in a human infant where the method involves enterally administering arginine and glutamine to the infant in about equimolar amounts to provide a total amount of arginine and glutamine that is effective to prevent or treat the abnormal vascular proliferation. Arginyl-glutamine dipeptide was shown to be an advantageous form in which to provide the two amino acids.

    摘要翻译: 本发明提供了一种用于预防和/或治疗人类婴儿异常血管增生的方法和组合物,其中所述方法涉及以约等摩尔量向婴儿肠内施用精氨酸和谷氨酰胺,以提供总量的精氨酸和谷氨酰胺,其对 预防或治疗异常血管增生。 显示出精氨酰 - 谷氨酰胺二肽是提供两种氨基酸的有利形式。